20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

BACKGROUND: The administration of endocrine therapy for 5 years substantially reduces recurrence rates during and after treatment in women with early-stage, estrogen-receptor (ER)–positive breast cancer. Extending such therapy beyond 5 years offers further protection but has additional side effects....

全面介紹

Na minha lista:
書目詳細資料
發表在:N Engl J Med
Main Authors: Pan, Hongchao, Gray, Richard, Braybrooke, Jeremy, Davies, Christina, Taylor, Carolyn, McGale, Paul, Peto, Richard, Pritchard, Kathleen I., Bergh, Jonas, Dowsett, Mitch, Hayes, Daniel F.
格式: Artigo
語言:Inglês
出版: 2017
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC5734609/
https://ncbi.nlm.nih.gov/pubmed/29117498
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa1701830
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍